Clinical factors and biomarkers associated with subclinical atherosclerosis in the human immunodeficiency virus infection;Factores clínicos y biomarcadores asociados a lesión vascular subclínica en la infección por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 139, Issue 6, 2012, Pages 231-237

  Serrano Villar, Sergio ^a   Estrada, Vicente ^a   Gómez Garre, Dulcenombre ^a   Ávila, Mario ^a   Fuentes Ferrer, Manuel ^a   Sánchez Parra, Clara ^a   Sainz, Talía ^b   De Carranza, María ^a   Fernández Cruz, Arturo ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cardiovascular risk factors; Carotid atherosclerosis; Clinical markers; Human immunodeficiency virus infection

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; AGE; ALBUMINURIA; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE;

ADULT; AGE FACTORS; AGED; ALBUMINURIA; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CAROTID INTIMA-MEDIA THICKNESS; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOSUPPRESSION; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK FACTORS; TIME FACTORS;

EID: 84864776318     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.12.018     Document Type: Article

References (33)

1. F.J. Palella Jr., R.K. Baker, A.C. Moorman, J.S. Chmiel, K.C. Wood, and J.T. Brooks Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study J Acquir Immune Defic Syndr 43 2006 27 34 (Pubitemid 44306484)
2. V.A. Triant, H. Lee, C. Hadigan, and S.K. Grinspoon Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 2007 2506 2512 (Pubitemid 47037350)
3. P.Y. Hsue, J.C. Lo, A. Franklin, A.F. Bolger, J.N. Martin, and S.G. Deeks Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection Circulation 109 2004 1603 1608 (Pubitemid 38451715)
4. M.G. Law, N. Friis-Moller, W.M. El Sadr, R. Weber, P. Reiss, and A. d'Arminio Monforte The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study HIV Med 7 2006 218 230
5. M.W. Lorenz, H.S. Markus, M.L. Bots, M. Rosvall, and M. Sitzer Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis Circulation 115 2007 459 467 (Pubitemid 46184197)
6. E. Hulten, J. Mitchell, J. Scally, B. Gibbs, and T.C. Villines HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies Heart 95 2009 1826 1835
7. C. Jerico, H. Knobel, N. Calvo, M.L. Sorli, A. Guelar, and J.L. Gimeno-Bayon Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy Stroke 37 2006 812 817 (Pubitemid 43731914)
8. C. Alonso-Villaverde, B. Coll, S. Parra, M. Montero, N. Calvo, and M. Tous Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele Circulation 110 2004 2204 2209 (Pubitemid 39372502)
9. B. Coll, S. Parra, C. Alonso-Villaverde, G. Aragones, M. Montero, and J. Camps The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection Stroke 38 2007 2477 2484 (Pubitemid 47329625)
10. F. Gutierrez, and M. Masia Enfermedad arterial periférica: un nuevo desafío para los pacientes con infección por el virus de la inmunodeficiencia humana Med Clin (Barc) 135 2010 546 548
11. A. Smith, C. Patterson, J. Yarnell, A. Rumley, Y. Ben Shlomo, and G. Lowe Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study Circulation 112 2005 3080 3087 (Pubitemid 43113439)
12. D.A. Duprez, J. Neuhaus, R. Tracy, L.H. Kuller, S.G. Deeks, and C. Orkin N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients AIDS 25 2011 651 657
13. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565 (Pubitemid 35315836)
14. L.B. Daniels, G.A. Laughlin, M.J. Sarno, R. Bettencourt, R.L. Wolfert, and E. Barrett-Connor Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study J Am Coll Cardiol 51 2008 913 919 (Pubitemid 351282456)
15. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 26 Suppl 1 2003 5 20
17. K.A. Lichtenstein, D.J. Ward, A.C. Moorman, K.M. Delaney, B. Young, and F.J. Palella Jr. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population AIDS 15 2001 1389 1398 (Pubitemid 32662290)
18. P.J. Touboul, M.G. Hennerici, S. Meairs, H. Adams, P. Amarenco, and N. Bornstein Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006 Cerebrovasc Dis 23 2007 75 80 (Pubitemid 46112808)
19. M. Secil, C. Altay, A. Gulcu, H. Cece, A.Y. Goktay, and O. Dicle Automated measurement of intima-media thickness of carotid arteries in ultrasonography by computer software Diagn Interv Radiol 11 2005 105 108 (Pubitemid 40894890)
20. E.A. Eugenin, S. Morgello, M.E. Klotman, A. Mosoian, P.A. Lento, and J.W. Berman Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease Am J Pathol 172 2008 1100 1111 (Pubitemid 351520006)
21. R.C. Kaplan, E. Sinclair, A.L. Landay, N. Lurain, A.R. Sharrett, and S.J. Gange T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women J Infect Dis 203 2011 452 463
22. N. Friis-Moller, P. Reiss, C.A. Sabin, R. Weber, A. Monforte, and W. El Sadr Class of antiretroviral drugs and the risk of myocardial infarction N Engl J Med 356 2007 1723 1735 (Pubitemid 46658704)
23. M. Gallego, R. Palacios, J. Olalla, F. Orihuela, J. Roldán, and J. Santos Colesterol ligado a lipoproteínas de baja densidad en una serie de pacientes con infección por el virus de la inmunodeficiencia humana Med Clin (Barc) 135 2010 202 204
24. M.W. Lorenz, C. Stephan, A. Harmjanz, S. Staszewski, A. Buehler, and M. Bickel Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis Atherosclerosis 196 2008 720 726
25. D. Salas, J. Olalla, A. del Arco, J. de La Torre, J.L. Prada, and M. Pombo Factores asociados a índice tobillo-brazo alterado en una cohorte de pacientes con infección por el virus de la inmunodeficiencia humana de tipo 1 Med Clin (Barc) 135 2010 533 536
26. R.C. Kaplan, L.A. Kingsley, S.J. Gange, L. Benning, L.P. Jacobson, and J. Lazar Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men AIDS 22 2008 1615 1624
27. P.W. Hunt, J. Brenchley, E. Sinclair, B. Bredt, E. Hagos, and H. Lampiris Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy J Infect Dis 197 2008 126 133 (Pubitemid 351263476)
28. K.O. Akosah, A. Schaper, C. Cogbill, and P. Schoenfeld Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 41 2003 1475 1479 (Pubitemid 36543362)
29. P.Y. Hsue, P.W. Hunt, A. Schnell, S.C. Kalapus, R. Hoh, and P. Ganz Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis AIDS 23 2009 1059 1067
30. M.S. Sabatine, D.A. Morrow, K.A. Jablonski, M.M. Rice, J.W. Warnica, and M.J. Domanski Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease Circulation 115 2007 1528 1536 (Pubitemid 46648637)
31. S. Lavi, J.P. McConnell, C.S. Rihal, A. Prasad, V. Mathew, and L.O. Lerman Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans Circulation 115 2007 2715 2721 (Pubitemid 46842787)
32. F.D. Kolodgie, A.P. Burke, K.S. Skorija, E. Ladich, R. Kutys, and A.T. Makuria Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis Arterioscler Thromb Vasc Biol 26 2006 2523 2529 (Pubitemid 44607475)
33. J.H. Stein, C.E. Korcarz, R.T. Hurst, E. Lonn, C.B. Kendall, and E.R. Mohler Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine J Am Soc Echocardiogr 21 2008 93 111 (Pubitemid 351193107)